@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAY6mvKY-nARInKjSkFD0SdPVY8IGb-hIZbs4hWustjhM> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAY6mvKY-nARInKjSkFD0SdPVY8IGb-hIZbs4hWustjhM#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix hgnc: <http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix go: <http://amigo.geneontology.org/amigo/term/GO:> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   sub:_1 geneProductOf: hgnc:4223 ;
    a Protein: .
  sub:_2 occursIn: obo:CL_0000746 , obo:UBERON_0001134 , species:9606 ;
    rdf:object go:0051450 ;
    rdf:predicate belv:decreases ;
    rdf:subject sub:_1 ;
    a rdf:Statement .
  sub:assertion rdfs:label "p(HGNC:MSTN) -| bp(GOBP:\"myoblast proliferation\")" .
}
sub:provenance {
   beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_4 ;
    pav:version "20131211" .
  sub:_3 prov:value "MuRF1 -/- and MAFbx -/- mice appear phenotypically normal. However, under atrophy conditions, significantly less muscle mass is lost in either MuRF1 -/- or MAFbx -/- animals in comparison with control littermates [11]. Myostatin However, when muscle obtained from myostatin -/- animals was analyzed, it was shown to be larger as a result of an increase in the number of muscle fibers, and not as a result of hypertrophy. Therefore, it was thought that myostatin acts in a way that is distinct from the activation of atrophy or the inhibition of hypertrophy; that it simply blocks the proliferation of muscle precursors, thus decreasing muscle mass." ;
    prov:wasQuotedFrom pubmed:12928036 .
  sub:_4 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:12928036 ;
    prov:wasDerivedFrom beldoc: , sub:_3 .
}
sub:pubinfo {
   this: dct:created "2014-07-03T14:32:07.466+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}